Article
Rational design and synthesis of 2-(1H-indazol-6-yl)-1H-benzo[d]imidazole derivatives as inhibitors targeting FMS-like tyrosine kinase 3 (FLT3) and its mutants.
Journal of enzyme inhibition and medicinal chemistry - 1 Dec 2022
Im Daseul, Jun Joonhong, Baek Jihyun, Kim Haejin, Kang Dahyun, Bae Hyunah, Cho Hyunwook, Hah Jung-Mi
Abstract excerpt
Fms-like tyrosine kinase 3 (FLT3) has been verified as a therapeutic target for acute myeloid leukaemia (AML). In this study, we report a series of 2-(1H-indazol-6-yl)-1H-benzo[d]imidazol-5-yl benzamide and phenyl urea derivatives as potent FLT3 inhibitors based on the structural optimisation of previous FLT3 inhibitors. Derivatives were synthesised as benzamide 8a-k, 8n-z, and phenyl urea 8l-m, with various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
